peptideEVIDENCECUSResearch chemical
Semax
Russian heptapeptide derived from ACTH 4-10. Used clinically in Russia for stroke and cognitive disorders. Intranasal.
Dose range0.3–1mg
Half-life0.5h
Onset15min
Safety3/5low evidence base
Mechanism of action
Increases BDNF and NGF in the hippocampus. Modulates dopamine and serotonin. Crosses BBB intranasally.
Benefits
Cognition / focus
EVIDENCECRussian clinical trials.
Stroke recovery
EVIDENCEBRussian RCTs.
Side effects
- Headacheuncommonmild
- Nasal irritationcommonmild
Where to buy
Affiliate linksNo vendor products listed yet. Vendors — list a product.